Morningstar8d
Royalty Pharma Reports Third Quarter 2024 Results
NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts.
24/7 Wall St4d
These Exclusive Resorts Are Reserved for the Ultra-Rich
Below, we’ll dig into exclusive resorts that are primarily for the ultra-rich, based on their reputation and price. Prices ...
BroadwayWorld8d
Pandion Music Foundation Details Free Music Industry Programs For November
Pandion Music Foundation (PMF) a nonprofit 501(c)(3) organization founded in 2022 dedicated to fostering growth in the music ...
Morningstar9d
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
Nov. 04, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that Royalty Pharma has entered into a $350 million synthetic royalty ...
U.S. Energy Industry Trends To Watch In A 2025 Trump Presidency
Donald Trump's reelection as President will impact the energy industry, but maybe not as expected. Energy, trade, regulatory, ...
Yahoo Finance23d
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
EMERYVILLE, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) announced today it has entered into a $15 million royalty monetization arrangement with Twist ...
Uranium Royalty Acquires Existing Royalty on Cameco's Advanced Stage Millennium and Cree Extension Uranium Projects
Detailed price information for Uranium Royalty Corp (URC-T) from The Globe and Mail including charting and trades.
Financial Post8d
Diversified Royalty Corp. Announces Third Quarter 2024 Results
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce its financial results for the three ...
Joplin Globe13d
Vox Royalty Provides Development Updates on Western Australia Gold Royalty Assets
TORONTO, ON / ACCESSWIRE / October 31, 2024 / Vox Royalty Corp. (TSX:VOXR)(NASDAQ:VOXR) ("Vox" or the "Company"), a returns focused mining royalty company, is pleased to provide recent development and ...
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarterStrengthened ...
Joplin Globe9d
KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) (“KalVista”), today announced the closing of a synthetic royalty financing agreement with DRI Healthcare Trust (“DRI”) for up to $179 million, comprised ...
manilatimes8d
Royalty Pharma Reports Third Quarter 2024 Results
NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts. ...